Sabra Health Care REIT (SBRA) Rating Lowered to Strong Sell at ValuEngine

Sabra Health Care REIT (NASDAQ:SBRA) was downgraded by equities research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a report issued on Tuesday.

A number of other equities research analysts also recently weighed in on the company. Zacks Investment Research raised Sabra Health Care REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, March 28th. SunTrust Banks set a $22.00 target price on Sabra Health Care REIT and gave the stock a “buy” rating in a research report on Monday, January 22nd. Mizuho set a $18.00 target price on Sabra Health Care REIT and gave the stock a “hold” rating in a research report on Friday, February 23rd. Stifel Nicolaus reissued a “hold” rating and set a $21.00 target price (down from $22.00) on shares of Sabra Health Care REIT in a research report on Thursday, February 22nd. Finally, Raymond James raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating in a research report on Monday. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $22.50.

SBRA stock opened at $19.93 on Tuesday. Sabra Health Care REIT has a twelve month low of $15.77 and a twelve month high of $25.31. The stock has a market cap of $3.49 billion, a P/E ratio of 8.20, a PEG ratio of 2.56 and a beta of 0.64. The company has a debt-to-equity ratio of 0.98, a quick ratio of 1.55 and a current ratio of 1.55.

Sabra Health Care REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, May 9th. The real estate investment trust reported $0.34 earnings per share for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.04). Sabra Health Care REIT had a return on equity of 7.19% and a net margin of 39.69%. The firm had revenue of $166.09 million for the quarter, compared to analyst estimates of $161.90 million. sell-side analysts predict that Sabra Health Care REIT will post 2.51 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Principal Financial Group Inc. boosted its holdings in Sabra Health Care REIT by 2.7% during the first quarter. Principal Financial Group Inc. now owns 783,727 shares of the real estate investment trust’s stock valued at $13,833,000 after purchasing an additional 20,435 shares in the last quarter. Xact Kapitalforvaltning AB boosted its holdings in Sabra Health Care REIT by 38.4% during the first quarter. Xact Kapitalforvaltning AB now owns 25,606 shares of the real estate investment trust’s stock valued at $452,000 after purchasing an additional 7,100 shares in the last quarter. Royal Bank of Canada boosted its holdings in Sabra Health Care REIT by 14.8% during the first quarter. Royal Bank of Canada now owns 166,361 shares of the real estate investment trust’s stock valued at $2,937,000 after purchasing an additional 21,434 shares in the last quarter. Legal & General Group Plc boosted its holdings in Sabra Health Care REIT by 16.9% during the first quarter. Legal & General Group Plc now owns 696,144 shares of the real estate investment trust’s stock valued at $12,287,000 after purchasing an additional 100,630 shares in the last quarter. Finally, Amundi Pioneer Asset Management Inc. boosted its holdings in Sabra Health Care REIT by 52.9% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 284,968 shares of the real estate investment trust’s stock valued at $5,030,000 after purchasing an additional 98,532 shares in the last quarter. 87.84% of the stock is currently owned by institutional investors.

About Sabra Health Care REIT

As of December 31, 2017, Sabra's investment portfolio included 507 real estate properties held for investment (consisting of (i) 384 Skilled Nursing/Transitional Care facilities, (ii) 88 Senior Housing – Leased communities, (iii) 13 Senior Housing – Managed communities and (iv) 22 Acute Care Hospitals), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) two mortgage loans, (ii) two construction loans, (iii) two mezzanine loans, (iv) one pre-development loan and (v) 15 other loans), 12 preferred equity investments and one investment in a specialty valuation firm.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply